• E-4031 in 3D Cardiac Electrophysiology

  2026-09-10

  Use E-4031 as a controlled hERG potassium channel blocker challenge for mapping repolarization changes, conduction instability, and arrhythmia-like events in three-dimensional cardiac organoids. This workflow pairs shell microelectrode arrays with calcium imaging to distinguish true electrophysiological effects from geometry, contact, or solvent artifacts.

• 5X Protein Loading Buffer (Reducing) Guide

  2026-09-10

  5X Protein Loading Buffer (Reducing) simplifies reducing protein sample preparation for conventional SDS-PAGE by combining SDS, a sulfhydryl reducing agent, buffer salts, and bromophenol blue. It is intended for denaturing, reducing workflows and should not be used when native structure, protein complexes, or disulfide bonds must be preserved.

• Shaped ABC Coil-Bottlebrush Self-Assembly

  2026-09-09

  The reference study examines how digitally shaped bottlebrush blocks alter phase selection in ABC coil–brush–brush terpolymers. Across a systematic library, SAXS identified predominantly hexagonal and lamellar structures, while the expected double-gyroid window was strongly suppressed and ordering remained unexpectedly slow.

• Fluconazole and the Next Frontier of Mucosal Defense

  2026-09-09

  The discovery of secreted METTL9 as a catalytic antifungal defense reframes how translational researchers can study Candida biology. This article connects host-mediated zinc restriction with Fluconazole-driven disruption of ergosterol biosynthesis, offering a strategic framework for resistance studies, infection modeling, and more informative antifungal susceptibility workflows.

• Matrine and Thymoma Stemness: Assay Logic

  2026-09-08

  Matrine is an anticancer alkaloid with emerging activity against thymoma stemness and apoptosis. This article develops an evidence-weighted assay strategy that connects YTHDF1–Wnt/β-catenin findings with formulation, endpoint selection, and inflammation-model validation.

• Pol II Degradation and Transcription-Independent Cell Death

  2026-09-08

  The preprint proposes that degradation of RNA polymerase II can activate regulated cell death through a mechanism that is not explained solely by global transcriptional shutdown. Its experimental logic separates loss of the Pol II protein from loss of transcription, offering a framework for interpreting cell-death and apoptosis assays in cancer research.

• GPNMB Model Predicts Immunotherapy Response in ESCC

  2026-09-07

  This study identifies circulating soluble GPNMB as a mechanistic and predictive marker of resistance to PD-1 blockade in esophageal squamous cell carcinoma. By combining plasma GPNMB, CAF-Epi niche features, and clinicopathological variables, the authors establish a multimodal framework that links tumor–immune biology with clinically usable response prediction.

• HyperFluor 488 Goat Anti-Rabbit IgG Guide

  2026-09-07

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, microscopy, and flow cytometry workflows. It is appropriate when a green fluorescent secondary is compatible with the imaging system, but it should not be treated as a substitute for primary-antibody validation or as evidence of performance in an untested tissue or assay.

• O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia

  2026-09-05

  The reference study identifies an O-GlcNAc–HUWE1–TfR1 pathway that connects protein modification, iron uptake, ferroptosis, and trophoblast syncytialization in preeclampsia. Its findings indicate that increasing O-GlcNAcylation stabilizes HUWE1, promotes TfR1 ubiquitination and degradation, and improves placental and pregnancy-related phenotypes in experimental models.

• Perifosine (KRX-0401) Workflow Guide

  2026-09-04

  Perifosine (KRX-0401) provides a practical pharmacological route to perturb Akt signaling while monitoring apoptosis, pathway feedback, and treatment sensitization. This guide translates cancer-cell evidence and a cerebral ischemia/reperfusion study into assay-ready workflows, controls, and troubleshooting strategies.

• ML216 BLM Helicase Inhibitor Workflow Guide

  2026-09-04

  ML216 enables mechanism-focused studies of BLM-dependent DNA repair, sister chromatid exchange, and genotype-selective cell responses. This workflow guide connects biochemical inhibition with cell proliferation inhibition assays and translational oncology models while clearly separating BLM biology from WRN-centered evidence.

• Digoxin Beyond the Pump: A Translational Playbook

  2026-09-03

  A mechanistic and translational framework for using Digoxin in cardiac, antiviral, and exposure-aware research while avoiding overinterpretation across models.

• Vacuolin-1 in Lysosomal Disease Assays

  2026-09-02

  Vacuolin-1 is a selective lysosomal exocytosis inhibitor for separating lysosome–plasma membrane fusion from downstream protease and growth-factor effects. This guide translates recent MPS IVA findings into a rigorous, interpretation-first assay strategy.

• Polymyxin B Sulfate in Infection Research

  2026-09-02

  Polymyxin B sulfate combines rapid membrane-disruptive antibacterial activity with a useful immunobiology profile for infection, dendritic-cell, and host–microbiome studies. This practical guide covers assay setup, experimental controls, protocol starting points, and troubleshooting for translating the reagent into reproducible research workflows.

• TMRE for Mitochondrial Membrane Potential Assays

  2026-09-01

  Tetramethylrhodamine ethyl ester perchlorate is a rhodamine-like fluorescent dye for live-cell measurement of mitochondrial membrane potential. C8197 supports mitochondria fluorescence imaging and flow-cytometric assays, but its signal should be interpreted as a potential-sensitive readout rather than a direct measurement of ROS, apoptosis, or mitochondrial mass.

7941 records 1/530 page Next 12345 下5页 Last page